Moderna

Company Overview

Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".

Industry

Biotechnology

Financial Summary

Revenue (TTM)

$803.00M

Net Income (TTM)

$8.36B

Total Assets

$18.43B

Total Debt

-

Total Equity

$14.14B

Market Cap

-

Valuation Metrics

P/E Ratio

-

P/B Ratio

-

Profit Margin

1041.34%

ROE

59.12%

ROA

45.38%

Dividend Yield

-

More Health Care Stocks